進行再発胃癌に対するTXL+CPT-11併用療法の多施設共同第Ⅰ/Ⅱ相試験
研究実績
検索結果:
すべて の研究実績
進行再発胃癌に対するWeekley投与によるTXL+CPT-11併用療法の第Ⅰ/Ⅱ相臨床試験(OGSG0104)
TS-1抵抗性の進行・再発胃癌に対するPaclitaxel/Doxifluridine併用療法の第Ⅱ相臨床試験(OGSG0302)
Multicenter phase II study of antimicrobial prophylaxis in low-risk patients undergoing distal gastrectomy for gastic cancer
PhaseII study of protracted irinotecan infusion and a low-dose cisplatinfor metastatic gastric cancer
Phase I/II study of combination chemotherapy with UFT/LV + CPT-11 in patients with advanced colorectal cancer (OGSG0303)
Phase I/II Study of weekly Taxol(TXL) plus CPT-11 for patients with advanced/recurrent gastic cancer (AGC/RGC)
Phase II study of a new regimen for S-1 therapy aiming at adverse reaction mitigation for metastatic gastric cancer: a study by the Osaka Gastrointestinal Chemotherapy Study Group OGSG-0103
Phase II study of paclitaxel and doxifluridine in patients with S-1 failure gastric cancer
進行・再発大腸癌に対するUFT/LV+CPT-11併用化学療法の第I相試験(OGSG0303)